Constantine G, Ranasinghe P, Weeratunga P, Weeraratne C, Galappatthy P, Rajapakse S
Trials. 2017; 18(1):124.
PMID: 28292320
PMC: 5351190.
DOI: 10.1186/s13063-017-1863-1.
van Tellingen C
Neth Heart J. 2015; 12(11):497-503.
PMID: 25696275
PMC: 2497415.
Sealey J
Am J Hypertens. 2014; 27(8):1019-23.
PMID: 25103936
PMC: 4125340.
DOI: 10.1093/ajh/hpu110.
Turner S, Schwartz G, Chapman A, Beitelshees A, Gums J, Cooper-DeHoff R
Am J Hypertens. 2010; 23(9):1014-22.
PMID: 20725057
PMC: 2941699.
DOI: 10.1038/ajh.2010.98.
Dodek A, Wilkins G
Can Fam Physician. 2010; 22:61-73.
PMID: 20469276
PMC: 2378364.
Drug therapy of renovascular hypertension.
Rosenthal T
Drugs. 1993; 45(6):895-909.
PMID: 7691497
DOI: 10.2165/00003495-199345060-00003.
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.
Weidmann P
Klin Wochenschr. 1980; 58(19):1071-89.
PMID: 7453095
DOI: 10.1007/BF01476878.
Drug-induced electrolyte abnormalities.
Brass E, Thompson W
Drugs. 1982; 24(3):207-28.
PMID: 6751789
DOI: 10.2165/00003495-198224030-00002.
The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men.
MacDonald I, Bennett T, Brown A, Wilcox R, Skene A
Br J Clin Pharmacol. 1984; 17(3):283-93.
PMID: 6370283
PMC: 1463374.
DOI: 10.1111/j.1365-2125.1984.tb02343.x.
Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists?.
Raftery E
Drugs. 1984; 28(5):371-4.
PMID: 6150842
DOI: 10.2165/00003495-198428050-00001.
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.
Man in t Veld A, SCHALEKAMP M
Br J Clin Pharmacol. 1982; 13(Suppl 2):245S-257S.
PMID: 6125175
PMC: 1402134.
DOI: 10.1111/j.1365-2125.1982.tb01922.x.
Response of the renin-angiotensin-aldosterone system to upright tilting and to intravenous frusemide: effect of prior metoprolol and propranolol.
Sonkodi S, Agabiti-Rosei E, Fraser R, Leckie B, Morton J, Cumming A
Br J Clin Pharmacol. 1982; 13(3):341-50.
PMID: 6120716
PMC: 1402119.
DOI: 10.1111/j.1365-2125.1982.tb01384.x.
Anaesthetic problems associated with the treatment of cardiovascular disease: II. Beta-adrenergic antagonists.
Chung D
Can Anaesth Soc J. 1981; 28(2):105-13.
PMID: 6113884
DOI: 10.1007/BF03007252.
Studies on the antihypertensive action of the optical isomers of propranolol in man.
Rahn K, HAWLINA A, Kersting F, Planz G
Naunyn Schmiedebergs Arch Pharmacol. 1974; 286(3):319-23.
PMID: 4281888
DOI: 10.1007/BF00498314.
Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber M, Stokes G, Gain J
J Clin Invest. 1974; 54(6):1413-9.
PMID: 4154950
PMC: 301696.
DOI: 10.1172/JCI107888.
Antihypertensive treatment according to age, plasma renin and race.
Buhler F
Drugs. 1988; 35(5):495-503.
PMID: 2899494
DOI: 10.2165/00003495-198835050-00001.
Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects.
Attman P, Aurell M, Johnsson G
Eur J Clin Pharmacol. 1975; 8(3-4):201-4.
PMID: 1233219
DOI: 10.1007/BF00567115.
Changes of plasma renin, angiotensin II and renin substrate during reversal of malignant renovascular hypertension.
Schultze G, Oelkers W
Klin Wochenschr. 1975; 53(23):1115-9.
PMID: 1206969
DOI: 10.1007/BF01614279.
The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
Lancaster R, Goodwin T, Peart W
Br J Clin Pharmacol. 1976; 3(3):453-60.
PMID: 973972
PMC: 2958755.
DOI: 10.1111/j.1365-2125.1976.tb00621.x.
Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.
Stumpe K, Kolloch R, Gramann W, Vetter H, Ressel C, Higuchi M
Klin Wochenschr. 1976; 54(16):775-82.
PMID: 957599
DOI: 10.1007/BF01614294.
